Glucagon-like peptide-1 receptor agonists vs. insulin in inadequately controlled patients with type 2 diabetes. Is this meta-analysis miscalculated?

Diabetes Obes Metab. 2014 Mar;16(3):284. doi: 10.1111/dom.12213.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucagon-Like Peptide 1 / therapeutic use*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*
  • Male
  • Receptors, Glucagon / agonists*

Substances

  • Hypoglycemic Agents
  • Insulin
  • Receptors, Glucagon
  • Glucagon-Like Peptide 1